News

Forma will receive an upfront payment, equity investment, payments for compounds delivered and research funding over the three-year collaboration term totaling up to $14 million and is eligible

The study was conducted at eight centers in the UK and enrolled a total of 36 patients. The patients were randomized into two equal size groups, one receiving

The appointment signals the company’s mission to further expand its clinical trial service capabilities with Mr MacGarvey managing the company’s initiatives in support of existing and new US

The Spectral OCT SLO combination imaging system is currently marketed internationally by the company’s subsidiary, Opko Instrumentation. According to the company, the Spectral OCT SLO is a non-contact,

Kennedy continues to serve as a member of the board of directors of IVAX. Kennedy has also informed IVAX that he plans to maintain a large equity interest

Biopsy data showed that injection of the drug into the muscles of a series of Duchenne muscular dystrophy (DMD) patients successfully induced dystrophin production in each patient. The

Drugs for Neglected Diseases initiative (DNDi) will collaborate with BDSI on a non-exclusive basis in the design and conduct of a research and clinical development program to assess

The lots are being voluntarily recalled as a precaution following a notification issued by China’s State Food and Drug Administration (SFDA) of the possibility of a flaw in

“In the quarter, and in the past year, we’ve taken decisive action as a BioPharma leader to become leaner and more agile,” said James M. Cornelius, chairman and